Magic mushroom compound tested for OCD – could it ease symptoms?
NCT ID NCT06992999
First seen Oct 31, 2025 · Last updated May 05, 2026 · Updated 26 times
Summary
This study tests whether psilocybin, the active ingredient in magic mushrooms, can safely reduce OCD symptoms. Twenty adults with moderate-to-severe OCD who haven't improved with standard treatments will receive either a low (10mg) or high (30mg) dose in four supervised sessions over 12 weeks. Researchers will track symptom changes, brain activity, and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Arizona-Tucson
Tucson, Arizona, 85724, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.